lymph node-targeted platform
Amplifying the immune response to defeat solid tumors

lymph node-targeted platform
Amplifying the immune response to defeat solid tumors

lymph node-targeted platform
Amplifying the immune response to defeat solid tumors

At Elicio, we engineer cancer immunotherapies that harness the natural power of our immune system

Our targeted-delivery approach generates robust immune responses that activate and amplify cancer-fighting T cells, potentially setting patients up to fight aggressive tumors with success.

Illustrated cancer cells

One platform, vast possibilities for cancer treatment

We develop next-generation vaccines, immunomodulators, and adjuvants that are built with our AMP platform. Our goal is to defeat the most challenging cancers, with a focus on pancreatic ductal adenocarcinoma (PDAC).

A dynamic powerhouse of immuno-oncology experts

With expertise in materials science, immunology, and cancer therapy, we bring together the best as we forge a new path forward.